Key dates
- 2015-05-01
- Relevant fictitious fuel oil transactions took place in 2015 between NUR Clean and two external parties
- 2015-12-31
- NUR’s 2015 annual results and report contained the misleading statements referenced by the SFC
- 2022-07-01
- The SFC commenced section 214 proceedings in July 2022
- 2025-11-18
- The Court of First Instance approved disposal of the proceedings against Tian by the Carecraft procedure and made the six-year disqualification order
Suggested considerations
- Compliance teams may wish to review whether directors and senior managers are making documented, independent decisions on related-party or high-value transactions rather than relying on pre-signed approvals.
- Firms may wish to assess controls over board approval, payment authorisation, and supporting trade documents for large commodity or trade-finance transactions.
- Listed issuers may wish to strengthen review of annual results and other market disclosures to ensure transaction narratives and financial reporting are not misleading.
- Governance functions may wish to test whether the company can evidence reasonable director diligence where counterparties are connected, opaque, or potentially circular in fund flows.
What changed
This publication does not introduce new rules or compliance obligations; it records an enforcement outcome under section 214 of the Securities and Futures Ordinance. The Court of First Instance, using the Carecraft procedure, approved agreed facts and ordered Tian disqualified for six years from acting as a director, liquidator, receiver or manager, or from being concerned in the management of any listed or unlisted Hong Kong corporation. Tian was also ordered to pay the SFC’s costs.
Compliance impact
The regulator’s message is that passive approval of dubious transactions, weak challenge over payment flows, and false reporting can lead to severe personal consequences, including multi-year director disqualification and costs orders. For listed groups, the case underscores heightened enforcement risk around fiduciary duty breaches, related-party arrangements, and disclosure integrity.